Georgetown Lombardi’s V. Craig Jordan Elected to London Fellowship

May 3, 2013

V. Craig Jordan, OBE, PhD, DSc, FMedSci, of Georgetown Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center, has been elected as a Fellow of the City & Guilds. Jordan is a scientist specializing in drugs for breast cancer treatment and prevention. He was elected for his pioneering research on tamoxifen and the discovery of a new group of medicines in women’s health the selective estrogen receptor modulators (SERMs). 

City & Guilds is the highest award conferred by the Council of the City & Guilds of London Institute. First awarded in 1892, it recognizes outstanding professional and personal achievement among “individuals who have demonstrated excellence in their field, gained the respect of their peers and can be considered role models for their profession.”

Jordan was one of 10 Fellows elected this cycle; there are approximately 400 Fellows in all (including 42 in the House of Lords). Previously elected Fellows include politicians, captains of industry, senior academics and former senior military officers. Jordan joins a small, but select, group of scientists who include: Professor Sir John Beddington (Government Chief Scientist), Professor Sir Leszek Borysiewicz (Vice Chancellor, Cambridge University), Professor Julia Buckingham (past President British Pharmacological Society), Professor Parveen Kumar (past President Royal Society of Medicine) and Professor Alan Roberts (past vice President Royal Society of Medicine).